tiprankstipranks
Trending News
More News >

Amneal Pharmaceuticals Shares Surge Amid Growth Prospects

Amneal Pharmaceuticals Shares Surge Amid Growth Prospects

Amneal Pharmaceuticals ( (AMRX) ) is experiencing volatility. Read on for a possible explanation for the stock’s unusual movement.

Confident Investing Starts Here:

Amneal Pharmaceuticals’ stock has been on the rise following a Buy rating from Goldman Sachs, which set a price target of $12, driven by expected growth in their generics segment and a robust product pipeline. Despite a recall of three lots of Sulfamethoxazole/Trimethoprim tablets due to contamination concerns, the company’s strong Q1 2025 results and recent FDA approvals have kept investor sentiment positive.

More about Amneal Pharmaceuticals

YTD Price Performance: -7.60%

Average Trading Volume: 1,903,387

Technical Sentiment Signal: Hold

Current Market Cap: $2.26B

For further insights into AMRX stock on TipRanks’ Stock Analysis page.

See more of today’s top stock gainers and losers.

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.

Report an Issue